Skip to main content

Sulfamylon Side Effects

Generic name: mafenide topical

Medically reviewed by Drugs.com. Last updated on Sep 6, 2024.

Note: This document provides detailed information about Sulfamylon Side Effects associated with mafenide topical. Some dosage forms listed on this page may not apply specifically to the brand name Sulfamylon.

Applies to mafenide topical: topical cream, topical powder for solution.

Common side effects of Sulfamylon

Some side effects of mafenide topical may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common side effects

  • pain or burning feeling on treated area(s)

Incidence unknown

Serious side effects of Sulfamylon

Along with its needed effects, mafenide topical (the active ingredient contained in Sulfamylon) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking mafenide topical:

Less common side effects

Rare side effects

  • bleeding or oozing of skin
  • drowsiness
  • fast, deep breathing
  • nausea

Incidence unknown

For healthcare professionals

Applies to mafenide topical: compounding powder, topical cream, topical powder for reconstitution.

General adverse events

In the clinical setting of severe burns, it is difficult to distinguish between an adverse reaction to this drug and burn sequelae. In a clinical study in pediatric patients with acute burns requiring autografts who received the topical solution in addition to double antibiotic solution (DAB) wound therapy (neomycin sulfate 40 mg and polymyxin B 200,000 units/L), the incidence of rash (4.6%) and itching (2.8%) in the group who received this drug was not different from that experienced with DAB dressings alone (5.7% and 1.3%, respectively).[Ref]

Local

Dermatologic

Respiratory

Metabolic

Hematologic

Other

References

1. (2022) "Product Information. Sulfamylon (mafenide topical)." Dow Hickam Pharmaceuticals Inc

2. (2003) "Product Information. Sulfamylon (mafenide topical)." Bertek Pharmaceuticals Inc

Further information

Sulfamylon side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.